Funding cutting-edge neuromuscular research has always been a priority for Muscular Dystrophy Canada. We support research here in Canada, as well as internationally, through our partnership with the Canadian Institute for Health Research (CIHR). With more new treatments than ever in development, this is a very exciting time in the neuromuscular community.
Our goal is to increase our investment in innovative research so we can continue accelerating the development of more treatments. This includes enabling the translation of basic research into clinical trials, establishing key partnerships and proactively addressing challenges in the drug development and regulatory process to ensure our clients have the information they need and access to these treatments at an affordable price.